GlassScriptPhysician profile
Sayuj Paudel
NPI 1932330883
$3,946.22
in general payments reported to CMS, 2019-2025
19 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $106 · 2021: $1,749 · 2023: $1,259 · 2024: $201 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,450 · Food and Beverage: $365 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,450.00 |
| Food and Beverage | $364.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $2,787.56 | 2021-2023 | Veklury |
| Atrium Medical Corporation | $400.00 | 2025 | Flixene |
| Genzyme Corporation | $185.00 | 2019 | |
| Becton, Dickinson and Company | $93.62 | 2021-2024 | Bd Introsyte |
| Novo Nordisk INC | $73.97 | 2021-2024 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $72.84 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.84 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $39.93 | 2020-2024 | Capvaxive, Gardasil 9, Gardasil |
| Amgen INC. | $28.21 | 2020-2021 | |
| Pfizer INC. | $28.05 | 2023 | |
| Glaxosmithkline, LLC. | $25.00 | 2024 | Arexvy |
| Sanofi-Aventis U.S. LLC | $22.29 | 2020 | |
| Corcept Therapeutics | $21.34 | 2021 | |
| Linus Health, INC. | $18.53 | 2024 | Core Cognitive Evaluation |
| Radius Health, INC. | $17.48 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.59 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.52 | 2019 | |
| Medtronic, INC. | $14.46 | 2021 | |
| Medtronic Minimed, INC. | $13.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sayuj Paudel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.